Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Actuate Therapeutics Inc (ACTU)

Actuate Therapeutics Inc (ACTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Actuate Therapeutics Inc 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 USA

https://actuatetherapeutics.com Employees: 10 P: 817-887-8455

Sector:

Medical

Description:

Actuate Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers. The company's lead product includes elraglusib. Actuate Therapeutics Inc. is based in FORT WORTH, Texas.

Key Statistics

Overview:

Market Capitalization, $K 132,253
Enterprise Value, $K 123,613
Shares Outstanding, K 23,243
Float, K 7,126
% Float 30.66%
Short Interest, K 530
Short Float 2.28%
Days to Cover 6.76
Short Volume Ratio 0.77
% of Insider Shareholders 69.34%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -27,290 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,410 K
EBIT, $ -24,370 K
EBITDA, $ -24,370 K

Growth:

1-Year Return -35.44%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 11/13/25
Next Earnings Date 03/12/26
Earnings Per Share ttm -0.87
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 54.55%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ACTU Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -2,925.12%
Return-on-Assets % -250.69%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 12.09
Book Value/Share 0.47
Interest Coverage -1,363.50
60-Month Beta -0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar